» Articles » PMID: 36866411

How Reliable Are Chinese Hamster Ovary (CHO) Cell Genome-scale Metabolic Models?

Overview
Publisher Wiley
Specialty Biochemistry
Date 2023 Mar 3
PMID 36866411
Authors
Affiliations
Soon will be listed here.
Abstract

Genome-scale metabolic models (GEMs) possess the power to revolutionize bioprocess and cell line engineering workflows thanks to their ability to predict and understand whole-cell metabolism in silico. Despite this potential, it is currently unclear how accurately GEMs can capture both intracellular metabolic states and extracellular phenotypes. Here, we investigate this knowledge gap to determine the reliability of current Chinese hamster ovary (CHO) cell metabolic models. We introduce a new GEM, iCHO2441, and create CHO-S and CHO-K1 specific GEMs. These are compared against iCHO1766, iCHO2048, and iCHO2291. Model predictions are assessed via comparison with experimentally measured growth rates, gene essentialities, amino acid auxotrophies, and C intracellular reaction rates. Our results highlight that all CHO cell models are able to capture extracellular phenotypes and intracellular fluxes, with the updated GEM outperforming the original CHO cell GEM. Cell line-specific models were able to better capture extracellular phenotypes but failed to improve intracellular reaction rate predictions in this case. Ultimately, this work provides an updated CHO cell GEM to the community and lays a foundation for the development and assessment of next-generation flux analysis techniques, highlighting areas for model improvements.

Citing Articles

Comprehensive stable-isotope tracing of glucose and amino acids identifies metabolic by-products and their sources in CHO cell culture.

Gonzalez J, Naik H, Oates E, Dhara V, McConnell B, Kumar S Proc Natl Acad Sci U S A. 2024; 121(41):e2403033121.

PMID: 39365816 PMC: 11474065. DOI: 10.1073/pnas.2403033121.


Metabolic models predict fotemustine and the combination of eflornithine/rifamycin and adapalene/cannabidiol for the treatment of gliomas.

Kishk A, Pacheco M, Heurtaux T, Sauter T Brief Bioinform. 2024; 25(3).

PMID: 38701414 PMC: 11066901. DOI: 10.1093/bib/bbae199.


Towards advanced bioprocess optimization: A multiscale modelling approach.

Monteiro M, Fadda S, Kontoravdi C Comput Struct Biotechnol J. 2023; 21:3639-3655.

PMID: 37520284 PMC: 10371800. DOI: 10.1016/j.csbj.2023.07.003.


How reliable are Chinese hamster ovary (CHO) cell genome-scale metabolic models?.

Strain B, Morrissey J, Antonakoudis A, Kontoravdi C Biotechnol Bioeng. 2023; 120(9):2460-2478.

PMID: 36866411 PMC: 10952175. DOI: 10.1002/bit.28366.

References
1.
De Martino D, Capuani F, Mori M, De Martino A, Marinari E . Counting and correcting thermodynamically infeasible flux cycles in genome-scale metabolic networks. Metabolites. 2014; 3(4):946-66. PMC: 3937828. DOI: 10.3390/metabo3040946. View

2.
Schilling C, Letscher D, Palsson B . Theory for the systemic definition of metabolic pathways and their use in interpreting metabolic function from a pathway-oriented perspective. J Theor Biol. 2000; 203(3):229-48. DOI: 10.1006/jtbi.2000.1073. View

3.
Megchelenbrink W, Huynen M, Marchiori E . optGpSampler: an improved tool for uniformly sampling the solution-space of genome-scale metabolic networks. PLoS One. 2014; 9(2):e86587. PMC: 3925089. DOI: 10.1371/journal.pone.0086587. View

4.
Calmels C, McCann A, Malphettes L, Andersen M . Application of a curated genome-scale metabolic model of CHO DG44 to an industrial fed-batch process. Metab Eng. 2018; 51:9-19. DOI: 10.1016/j.ymben.2018.09.009. View

5.
Lorenzi M . The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient. Exp Diabetes Res. 2008; 2007:61038. PMC: 1950230. DOI: 10.1155/2007/61038. View